Cancer Research Cancer Epigenetics  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 3768-3775, August 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by David, K.
Right arrow Articles by Vogel, C.-W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by David, K.
Right arrow Articles by Vogel, C.-W.
[Cancer Research 59, 3768-3775, August 1, 1999]
© 1999 American Association for Cancer Research


Tumor Biology

Human Natural Immunoglobulin M Antibodies Induce Apoptosis of Human Neuroblastoma Cells by Binding to a Mr 260,000 Antigen1

Kerstin David2, Markus W. Ollert3, Caren Vollmert4, Sven Heiligtag, Britta Eickhoff, Rudolf Erttmann, Reinhard Bredehorst and Carl-Wilhelm Vogel2,5

Department of Biochemistry and Molecular Biology, University of Hamburg, 20146 Hamburg, Germany [K. D., M. W. O., C. V., S. H., R. B., C-W. V.], and Department of Pediatric Hematology and Oncology, University Hospital Eppendorf, University of Hamburg, 20246 Hamburg, Germany [B. E., R. E.]

Sera of healthy humans contain natural cytotoxic IgM antibodies that specifically recognize a Mr 260,000 antigen (NB-p260) on the surface of human neuroblastoma (NB) cells. Here we demonstrate that anti-NB IgM antibodies prepared from different healthy individuals induce, in all human NB cell lines analyzed thus far, typical morphological and biochemical features of apoptosis including nuclear fragmentation, chromatin condensation, and DNA fragmentation. Both the binding of human anti-NB IgM to NB cells and the induction of apoptosis could be inhibited by preincubation of NB cells with murine IgG raised against purified NB-p260. Furthermore, preincubation of human anti-NB IgM with purified NB-p260 immobilized onto a solid support abolished its ability to induce apoptosis in NB cells. Natural human anti-NB IgM failed to bind to and induce apoptosis in control tumor cell lines that lack expression of NB-p260. The anti-NB IgM-induced apoptotic response was also observed in vivo in xenografted human NB tumors. After a single i.v. injection of anti-NB IgM into nude rats bearing solid NB xenografts, many areas of pyknotic cells with fragmented nuclei were observed that stained positive using the terminal dUTP nick end labeling method. In conclusion, the data demonstrate that natural anti-NB IgM antibodies in the sera of healthy individuals are potent mediators of apoptotic cell death of NB cells both in vitro and in vivo. The NB-p260 antigen was identified as the apoptosis-inducing receptor for anti-NB IgM. Whereas natural anti-NB IgM and NB-p260 may be useful tools for immunotherapy of NB, their biological significance remains to be determined.




This article has been cited by other articles:


Home page
BloodHome page
A. Lanemo Myhrinder, E. Hellqvist, E. Sidorova, A. Soderberg, H. Baxendale, C. Dahle, K. Willander, G. Tobin, E. Backman, O. Soderberg, et al.
A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies
Blood, April 1, 2008; 111(7): 3838 - 3848.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
F. Menegaux, A. F. Olshan, J. P. Neglia, B. H. Pollock, and M. L. Bondy
Day Care, Childhood Infections, and Risk of Neuroblastoma
Am. J. Epidemiol., May 1, 2004; 159(9): 843 - 851.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Brandlein, T. Pohle, N. Ruoff, E. Wozniak, H.-K. Muller-Hermelink, and H. P. Vollmers
Natural IgM Antibodies and Immunosurveillance Mechanisms against Epithelial Cancer Cells in Humans
Cancer Res., November 15, 2003; 63(22): 7995 - 8005.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Engler, C. Thiel, K. Förster, K. David, R. Bredehorst, and H. Juhl
A Novel Metastatic Animal Model Reflecting the Clinical Appearance of Human Neuroblastoma: Growth Arrest of Orthotopic Tumors by Natural, Cytotoxic Human Immunoglobulin M Antibodies
Cancer Res., April 1, 2001; 61(7): 2968 - 2973.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
N.-K. V. Cheung, H.-f. Guo, G. Heller, and I. Y. Cheung
Induction of Ab3 and Ab3' Antibody Was Associated with Long-Term Survival after Anti-GD2 Antibody Therapy of Stage 4 Neuroblastoma
Clin. Cancer Res., July 1, 2000; 6(7): 2653 - 2660.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.